pith. sign in

arxiv: 2605.19789 · v1 · pith:HRTIY2FDnew · submitted 2026-05-19 · 🧬 q-bio.TO

Charting an embryological path to cancer cure: A discussion of disease hallmarks

Jaime Cofre This is my paper

Pith reviewed 2026-05-20 01:26 UTC · model grok-4.3

classification 🧬 q-bio.TO
keywords cancerembryologyevolutiondisease hallmarkstherapeutic approachesdevelopmental biologyatavism
0
0 comments X

The pith

Cancer shares deep embryological roots that can guide new therapeutic strategies.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper argues that cancer is best understood as an embryological and evolutionary phenomenon rather than purely a genetic disorder. It highlights long-noted but under-discussed parallels between embryonic development and tumor behavior to propose a reframing of disease hallmarks. A sympathetic reader would care because this perspective could shift research toward therapies that target developmental programs reactivated in cancer, potentially addressing resistance and recurrence that plague existing treatments.

Core claim

Despite indisputable similarities between embryonic development and cancer, there has been limited discussion on the profound embryological implications for the disease; exploring cancer as an embryological and evolutionary phenomenon offers a fresh perspective with immediate consequences in the search for therapeutic approaches.

What carries the argument

Embryological reinterpretation of cancer disease hallmarks as an evolutionary reversion to developmental states

If this is right

  • Therapeutic development should prioritize targets drawn from normal embryonic gene regulation that become pathological in adults.
  • Evolutionary framing may explain tumor plasticity and resistance as reactivation of ancient developmental programs.
  • Hallmark-based classifications of cancer can be expanded or revised using embryological criteria to identify overlooked vulnerabilities.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • This framing may connect cancer research more tightly to regenerative medicine and developmental biology experiments.
  • Comparative transcriptomic studies between embryos and tumors could systematically reveal candidate drug targets.
  • If the approach succeeds it would support broader atavism models for other proliferative diseases.

Load-bearing premise

The observed similarities between embryonic development and cancer are deep enough and actionable enough to chart a practical path to new cures rather than remaining descriptive parallels.

What would settle it

No measurable improvement in cancer outcomes from therapies explicitly designed around embryonic or developmental pathways, or failure of such interventions to outperform standard treatments in controlled models.

Figures

Figures reproduced from arXiv: 2605.19789 by Jaime Cofre.

Figure 1
Figure 1. Figure 1: Hallmarks of cancer. (a) This panel presents the traditional hallmarks of [PITH_FULL_IMAGE:figures/full_fig_p012_1.png] view at source ↗
read the original abstract

Embryology has long played a foundational role in shaping our scientific understanding of animal evolution. In recent decades, growing evidence has also highlighted its role in cancer. Despite the indisputable similarities between embryonic development and cancer, there has been limited discussion on the profound embryological implications for the disease. This article explores the understanding of cancer as an embryological and evolutionary phenomenon, offering a fresh perspective on the disease and discussing immediate consequences in the search for therapeutic approaches

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 1 minor

Summary. The manuscript frames cancer as an embryological and evolutionary atavism, highlighting parallels between embryonic development and established cancer hallmarks. It argues that this perspective offers a fresh understanding of the disease and carries immediate implications for identifying new therapeutic strategies.

Significance. If the embryological lens can be shown to generate distinct, actionable interventions, the synthesis could help unify developmental biology with oncology and stimulate research into targeting reactivated embryonic programs. As a conceptual discussion without new data, derivations, or empirical tests, its primary value lies in reframing existing observations rather than delivering falsifiable predictions or mechanistic bridges.

major comments (2)
  1. [Abstract and therapeutic implications section] Abstract and the section on therapeutic consequences: the claim that the embryological perspective yields 'immediate consequences' for cancer cures is not supported by any concrete molecular targets, dosing rationales, or trial designs derived from the framing; the argument remains at the level of descriptive parallels without demonstrating how it alters clinical decision-making beyond existing hallmark-targeted therapies.
  2. [Hallmarks discussion] Discussion of disease hallmarks: observed similarities between embryonic programs and cancer are presented without addressing known confounding factors in such comparisons (e.g., shared use of proliferation and migration machinery) or providing a concrete test that would falsify the atavism interpretation versus standard oncogenic models.
minor comments (1)
  1. [Abstract] The abstract could more explicitly list the specific hallmarks addressed and the precise embryological features invoked for each.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their detailed review and valuable suggestions. We have carefully considered the comments and made revisions to strengthen the manuscript's clarity regarding its conceptual nature and implications.

read point-by-point responses

  1. Referee: [Abstract and therapeutic implications section] Abstract and the section on therapeutic consequences: the claim that the embryological perspective yields 'immediate consequences' for cancer cures is not supported by any concrete molecular targets, dosing rationales, or trial designs derived from the framing; the argument remains at the level of descriptive parallels without demonstrating how it alters clinical decision-making beyond existing hallmark-targeted therapies.

    Authors: We acknowledge that the manuscript is a conceptual discussion and does not derive specific molecular targets or trial designs. The phrase 'immediate consequences' was intended to indicate direct relevance to therapeutic thinking rather than immediate clinical application. We have revised the abstract and the therapeutic implications section to clarify that the embryological perspective suggests promising avenues for future research, such as targeting specific embryonic gene programs that are reactivated in cancer, while noting that these would require further experimental validation. This change better reflects the scope of the paper. revision: yes

  2. Referee: [Hallmarks discussion] Discussion of disease hallmarks: observed similarities between embryonic programs and cancer are presented without addressing known confounding factors in such comparisons (e.g., shared use of proliferation and migration machinery) or providing a concrete test that would falsify the atavism interpretation versus standard oncogenic models.

    Authors: The referee raises an important point about potential confounding factors. We agree that many cellular processes like proliferation and migration are shared between development and cancer, which could weaken claims of specific atavism. In the revised manuscript, we have expanded the hallmarks discussion to explicitly address these confounders and explain why the atavism view provides a distinct framework by emphasizing the coordinated reactivation of developmental regulatory networks. Regarding a falsifying test, as this is a discussion paper without new empirical data, we cannot provide one here; however, we have suggested potential experimental designs, such as functional assays comparing embryonic and tumor cells, that could help differentiate the models in future work. revision: partial

Circularity Check

0 steps flagged

No circularity: interpretive discussion builds on known parallels without self-referential reduction

full rationale

The paper is a conceptual discussion piece that reviews established similarities between embryonic development and cancer to frame the disease as an embryological and evolutionary phenomenon and to suggest therapeutic implications. No mathematical derivations, parameter fittings, or first-principles predictions are presented that could reduce to the paper's own inputs by construction. The central framing relies on prior biological observations but does not define its claims in terms of those observations tautologically, nor does it invoke self-citations as load-bearing uniqueness theorems. As such, the argument remains interpretive rather than deductive, with no steps that qualify as self-definitional, fitted-input predictions, or ansatz smuggling.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

The central claim rests on the domain assumption that embryological mechanisms are sufficiently analogous to cancer processes to inform therapy design; no free parameters or invented entities are introduced as the work is conceptual.

axioms (1)
  • domain assumption Embryonic development and cancer share deep mechanistic similarities that have therapeutic implications.
    Invoked in the abstract as the basis for exploring cancer as an embryological phenomenon.

pith-pipeline@v0.9.0 · 5591 in / 1174 out tokens · 32414 ms · 2026-05-20T01:26:09.013567+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

58 extracted references · 58 canonical work pages

  1. [1]

    Hallmarks of Cancer: The Next Generation

    Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-674. doi:10.1016/j.cell.2011.02.013

    work page doi:10.1016/j.cell.2011.02.013 2011

  2. [2]

    The Hallmarks of Cancer

    Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000;100(1):57-70. doi:10.1016/S0092-8674(00)81683-9

    work page doi:10.1016/s0092-8674(00)81683-9 2000

  3. [3]

    Cell cycle dysregulation in cancer

    Glaviano A, Singh SK, Lee EHC, et al. Cell cycle dysregulation in cancer. Pharmacol Rev. 2025;77(2):100030

    work page 2025

  4. [4]

    Hypoxia -Induced Active Dynamics Promotes Early Tumorigenesis

    Wang Z, Tian L, Li B. Hypoxia -Induced Active Dynamics Promotes Early Tumorigenesis. bioRxiv.Cold Spring Harbor Laboratory. Preprint posted online January 2, 2025:2012-2024. doi:10.1101/2024.12.31.630973

    work page doi:10.1101/2024.12.31.630973 2025

  5. [5]

    The first embryo, the origin of cancer and animal phylogeny

    Cofre J. The first embryo, the origin of cancer and animal phylogeny. V . Cancer stem cells as the unifying biomechanical principle between embryology and oncology. Mechanobiology in Medicine. 2025;3(1):100110. doi:https://doi.org/10.1016/j.mbm.2024.100110

    work page doi:10.1016/j.mbm.2024.100110 2025

  6. [6]

    Syncytin and Cancer Cell Fusions

    Larsson LI, Bjerregaard B, Wulf-Andersen L, Talts JF . Syncytin and Cancer Cell Fusions. The Scientific World Journal. 2007;7:1193 -1197. doi:10.1100/tsw.2007.212

    work page doi:10.1100/tsw.2007.212 2007

  7. [7]

    Pluripotent teratocarcinoma -thymus somatic cell hybrids

    Miller RA, Ruddle FH. Pluripotent teratocarcinoma -thymus somatic cell hybrids. Cell. 1976;9(1):45-55. doi:https://doi.org/10.1016/0092-8674(76)90051-9

    work page doi:10.1016/0092-8674(76)90051-9 1976

  8. [8]

    Melanoma x macrophage hybrids with enhanced metastatic potential

    Rachkovsky M, Sodi S, Chakraborty A, et al. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis. 1998;16(4):299 -312. doi:10.1023/A:1006557228604

    work page doi:10.1023/a:1006557228604 1998

  9. [9]

    Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow -derived macrophage

    Larizza L, Schirrmacher V , Pflüger E. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow -derived macrophage. Journal of Experimental Medicine. 1984;160(5):1579 -1584. doi:10.1084/jem.160.5.1579

    work page doi:10.1084/jem.160.5.1579 1984

  10. [10]

    Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial -to-mesenchymal transition and malignant transformation

    He X, Li B, Shao Y , et al. Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial -to-mesenchymal transition and malignant transformation. BMC Cancer. 2015;15(1):24. doi:10.1186/s12885 -015- 1027-1

    work page doi:10.1186/s12885 2015

  11. [11]

    In vivo hybridisation of human tumour and normal hamster cells

    Goldenberg DM, Pavia RA, Tsao MC. In vivo hybridisation of human tumour and normal hamster cells. Nature. 1974;250(5468):649-651. doi:10.1038/250649a0

    work page doi:10.1038/250649a0 1974

  12. [12]

    Cell fusion: A hidden enemy? Cancer Cell

    Duelli D, Lazebnik Y . Cell fusion: A hidden enemy? Cancer Cell. 2003;3(5):445-448. doi:10.1016/S1535-6108(03)00114-4

    work page doi:10.1016/s1535-6108(03)00114-4 2003

  13. [13]

    Über Zellverschmelzung Mit Qualitativ Abnormer Chromosomenverteilung Als Ursache Der Geschwulstbildung

    Aichel O. Über Zellverschmelzung Mit Qualitativ Abnormer Chromosomenverteilung Als Ursache Der Geschwulstbildung. W. Engelmann; 1911

    work page 1911

  14. [14]

    An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

    Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40(5):499-507. doi:10.1038/ng.127

    work page doi:10.1038/ng.127 2008

  15. [15]

    MYC in cancer: from undruggable target to clinical trials

    Whitfield JR, Soucek L. MYC in cancer: from undruggable target to clinical trials. Nat Rev Drug Discov. Published online 2025:1-13

    work page 2025

  16. [16]

    Nonmuscle Myosin II in cancer cell migration and mechanotransduction

    Halder D, Mallick D, Chatterjee A, Jana SS. Nonmuscle Myosin II in cancer cell migration and mechanotransduction. Int J Biochem Cell Biol. 2021;139:106058. doi:10.1016/j.biocel.2021.106058

    work page doi:10.1016/j.biocel.2021.106058 2021

  17. [17]

    Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

    Friedl P , Alexander S. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity. Cell. 2011;147(5):992-1009. doi:10.1016/j.cell.2011.11.016

    work page doi:10.1016/j.cell.2011.11.016 2011

  18. [18]

    Complex networks orchestrate epithelial – mesenchymal transitions

    Thiery JP , Sleeman JP . Complex networks orchestrate epithelial – mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131 -142. doi:10.1038/nrm1835

    work page doi:10.1038/nrm1835 2006

  19. [19]

    An active role for basement membrane assembly and modification in tissue sculpting

    Morrissey MA, Sherwood DR. An active role for basement membrane assembly and modification in tissue sculpting. J Cell Sci. 2015;128(9):1661 -1668. doi:10.1242/jcs.168021

    work page doi:10.1242/jcs.168021 2015

  20. [20]

    Basement membrane remodeling guides cell migration and cell morphogenesis during development

    Sherwood DR. Basement membrane remodeling guides cell migration and cell morphogenesis during development. Curr Opin Cell Biol. 2021;72:19 -27. doi:https://doi.org/10.1016/j.ceb.2021.04.003

    work page doi:10.1016/j.ceb.2021.04.003 2021

  21. [21]

    Gastrulation in the sea anemone Nematostella vectensis occurs by invagination and immigration: an ultrastructural study

    Kraus Y , Technau U. Gastrulation in the sea anemone Nematostella vectensis occurs by invagination and immigration: an ultrastructural study. Dev Genes Evol. 2006;216(3):119-132. doi:10.1007/s00427-005-0038-3

    work page doi:10.1007/s00427-005-0038-3 2006

  22. [22]

    Mesenchymal -to-epithelial transitions require tissue-specific interactions with distinct laminins

    Pitsidianaki I, Morgan J, Adams J, Campbell K. Mesenchymal -to-epithelial transitions require tissue-specific interactions with distinct laminins. Journal of Cell Biology. 2021;220(8):e202010154. doi:10.1083/jcb.202010154

    work page doi:10.1083/jcb.202010154 2021

  23. [23]

    β-Pix-dependent cellular protrusions propel collective mesoderm migration in the mouse embryo

    Omelchenko T, Hall A, Anderson K V . β-Pix-dependent cellular protrusions propel collective mesoderm migration in the mouse embryo. Nat Commun. 2020;11(1):6066. doi:10.1038/s41467-020-19889-1

    work page doi:10.1038/s41467-020-19889-1 2020

  24. [24]

    The Role of Cnidaria in Drug Discovery

    Mariottini GL. The Role of Cnidaria in Drug Discovery. In: Goffredo S, Dubinsky Z, eds. The Cnidaria, Past, Present and Future: The World of Medusa and Her Sisters. Springer International Publishing; 2016:653 -668. doi:10.1007/978 -3- 319-31305-4_40

    work page doi:10.1007/978 2016

  25. [25]

    Exploring manzamine a: a promising anti- lung cancer agent from marine sponge Haliclona sp

    Su M, Zhu J, Bai L, Cao Y , Wang S. Exploring manzamine a: a promising anti- lung cancer agent from marine sponge Haliclona sp. Front Pharmacol. 2025;16:1525210. doi:10.3389/fphar.2025.1525210

    work page doi:10.3389/fphar.2025.1525210 2025

  26. [26]

    Normal genetically mosaic mice produced from malignant terat ocarcinoma cells

    Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant terat ocarcinoma cells. Proceedings of the National Academy of Sciences. 1975;72(9):3585-3589

    work page 1975

  27. [27]

    Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst

    Pierce GB, Lewis SH, Miller GJ, Moritz E, Miller P . Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst. Proceedings of the National Academy of Sciences. 1979;76(12):6649-6651

    work page 1979

  28. [28]

    The amoeboid state as part of the epithelial -to-mesenchymal transition programme

    Graziani V , Rodriguez -Hernandez I, Maiques O, Sanz -Moreno V . The amoeboid state as part of the epithelial -to-mesenchymal transition programme. Trends Cell Biol. 2022;32(3):228-242. doi:https://doi.org/10.1016/j.tcb.2021.10.004

    work page doi:10.1016/j.tcb.2021.10.004 2022

  29. [29]

    RhoA ‐ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic‐like flow

    Mohammadalipour A, Diaz MF , Livingston M, et al. RhoA ‐ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic‐like flow. FASEB Bioadv. 2022;4(5):342-361. doi:10.1096/fba.2021-00055

    work page doi:10.1096/fba.2021-00055 2022

  30. [30]

    Mesenchymal to amoeboid transition is associated with stem -like features of melanoma cells

    Taddei ML, Giannoni E, Morandi A, et al. Mesenchymal to amoeboid transition is associated with stem -like features of melanoma cells. Cell Communication and Signaling. 2014;12(1):24. doi:10.1186/1478-811X-12-24

    work page doi:10.1186/1478-811x-12-24 2014

  31. [31]

    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination

    Crosas-Molist E, Bertran E, Rodriguez-Hernandez I, et al. The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination. Oncogene. 2017;36(21):3002-3014. doi:10.1038/onc.2016.454

    work page doi:10.1038/onc.2016.454 2017

  32. [32]

    Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature

    Emad A, Ray T, Jensen TW, et al. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature. Breast Cancer Research. 2020;22(1):74. doi:10.1186/s13058-020-01304-8

    work page doi:10.1186/s13058-020-01304-8 2020

  33. [33]

    Live imaging of cell protrusive activity, and extracellular matrix assembly and remodeling during morphogenesis in the frog, Xenopus laevis

    Davidson LA, Dzamba BD, Keller R, Desimone DW. Live imaging of cell protrusive activity, and extracellular matrix assembly and remodeling during morphogenesis in the frog, Xenopus laevis. Developmental Dynamics. 2008;237(10):2684-2692. doi:10.1002/dvdy.21600

    work page doi:10.1002/dvdy.21600 2008

  34. [34]

    Presence of the matrix metalloproteinases during the migration of the primordial germ cells in zebrafish gonadal ridge

    Mazzoni TS, Quagio-Grassiotto I. Presence of the matrix metalloproteinases during the migration of the primordial germ cells in zebrafish gonadal ridge. Cell Tissue Res. 2021;383(2):707-722. doi:10.1007/s00441-020-03288-5

    work page doi:10.1007/s00441-020-03288-5 2021

  35. [35]

    How germline genes promote malignancy in cancer cells

    Bruggeman JW, Koster J, van Pelt AMM, Speijer D, Hamer G. How germline genes promote malignancy in cancer cells. BioEssays. 2023;45(1):2200112. doi:10.1002/bies.202200112

    work page doi:10.1002/bies.202200112 2023

  36. [36]

    Induced malignant genome reprogramming in somatic cells by testis -specific factors

    Wang J, Emadali A, Le Bescont A, Callanan M, Rousseaux S, Khochbin S. Induced malignant genome reprogramming in somatic cells by testis -specific factors. Biochim Biophys Acta Gene Regul Mech. 2011;1809(4 -6):221-225. doi:10.1016/j.bbagrm.2011.04.003

    work page doi:10.1016/j.bbagrm.2011.04.003 2011

  37. [37]

    Meta -analysis of expression of l(3)mbt tumor -associated germline genes supports the model that a soma -to- germline transition is a hallmark of human cancers

    Feichtinger J, Larcombe L, McFarlane RJ. Meta -analysis of expression of l(3)mbt tumor -associated germline genes supports the model that a soma -to- germline transition is a hallmark of human cancers. Int J Cancer. 2014;134(10):2359-2365. doi:10.1002/ijc.28577

    work page doi:10.1002/ijc.28577 2014

  38. [38]

    Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila

    Janic A, Mendizabal L, Llamazares S, Rossell D, Gonz alez C. Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila. Science (1979). 2010;330(6012):1824-1827. doi:10.1126/science.1195481

    work page doi:10.1126/science.1195481 1979

  39. [39]

    Spontaneous generation of germline characteristics in mouse fibrosarcoma cells

    Ma Z, Hu Y , Jiang G, et al. Spontaneous generation of germline characteristics in mouse fibrosarcoma cells. Sci Rep. 2012;2(1):743. doi:10.1038/srep00743

    work page doi:10.1038/srep00743 2012

  40. [40]

    Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis -Prone Lung Cancers

    Rousseaux S, Debernardi A, Jacquiau B, et al. Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis -Prone Lung Cancers. Sci Transl Med. 2013;5(186):186ra66. doi:10.1126/scitranslmed.3005723

    work page doi:10.1126/scitranslmed.3005723 2013

  41. [41]

    On the origin of cancer cells

    Warburg O. On the origin of cancer cells. Science (1979). 1956;123(3191):309-314. doi:10.1126/science.123.3191.30

    work page doi:10.1126/science.123.3191.30 1979

  42. [42]

    Oxygen a nd carbon dioxide in the marine intertidal environment: Diurnal and tidal changes in rockpools

    Truchot JP , Duhamel-Jouve A. Oxygen a nd carbon dioxide in the marine intertidal environment: Diurnal and tidal changes in rockpools. Respir Physiol. 1980;39(3):241-254. doi:https://doi.org/10.1016/0034-5687(80)90056-0

    work page doi:10.1016/0034-5687(80)90056-0 1980

  43. [43]

    Loss of the HIF pathway in a widely distributed intertidal crustacean, the copepod Tigriopus californicus

    Graham AM, Barreto FS. Loss of the HIF pathway in a widely distributed intertidal crustacean, the copepod Tigriopus californicus. Proc Natl Acad Sci U S A. 2019;116(26):12913-12918. doi:10.1073/pnas.1819874116

    work page doi:10.1073/pnas.1819874116 2019

  44. [44]

    The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci

    Liberti M V , Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41(3):211-218. doi:10.1016/j.tibs.2015.12.001

    work page doi:10.1016/j.tibs.2015.12.001 2016

  45. [45]

    Oxygen as a prerequisite to the origin of the Metazoa

    Nursall JR. Oxygen as a prerequisite to the origin of the Metazoa. Nature. 1959;183(4669):1170-1172

    work page 1959

  46. [46]

    Late -Neoproterozoic deep-ocean oxygenation and the rise of animal life

    Canfield DE, Poulton SW, Narbonne GM. Late -Neoproterozoic deep-ocean oxygenation and the rise of animal life. Science (1979). 2007;315(5808):92-95

    work page 1979

  47. [47]

    A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells

    Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells. Proc Natl Acad Sci U S A. 2003;100(14):8164-8169. doi:10.1073/pnas.1332764100

    work page doi:10.1073/pnas.1332764100 2003

  48. [48]

    Evaluation of Myc E -Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays

    Kim J whan, Zeller KI, Wang Y , et al. Evaluation of Myc E -Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays. Mol Cell Biol. 2004;24(13):5923-5936. doi:10.1128/MCB.24.13.5923-5936.2004

    work page doi:10.1128/mcb.24.13.5923-5936.2004 2004

  49. [49]

    Decoupled oxygenation of the Ediacaran ocean and atmosphere during the rise of early animals

    Shi W, Mills BJW, Li C, et al. Decoupled oxygenation of the Ediacaran ocean and atmosphere during the rise of early animals. Earth Planet Sci Lett. 2022;591:117619. doi:https://doi.org/10.1016/j.epsl.2022.117619

    work page doi:10.1016/j.epsl.2022.117619 2022

  50. [50]

    An early soda ocean? Chem Geol

    Kempe S, Degens ET. An early soda ocean? Chem Geol. 1985;53(1-2):95-108. doi:10.1016/0009-2541(85)90023-3

    work page doi:10.1016/0009-2541(85)90023-3 1985

  51. [51]

    The Voltage -Gated Proton Channel: A Riddle, Wrapped in a Mystery, inside an Enigma

    DeCoursey TE. The Voltage -Gated Proton Channel: A Riddle, Wrapped in a Mystery, inside an Enigma. Biochemistry. 2015;54(21):3250 -3268. doi:10.1021/acs.biochem.5b00353

    work page doi:10.1021/acs.biochem.5b00353 2015

  52. [52]

    A Voltage -Gated H+ Channel Underlying pH Homeostasis in Calcifying Coccolithophores

    Taylor AR, Chrachri A, Wheeler G, Goddard H, Brownlee C. A Voltage -Gated H+ Channel Underlying pH Homeostasis in Calcifying Coccolithophores. Falkowski PG, ed. PLoS Biol. 2011;9(6):e1001085. doi:10.1371/journal.pbio.1001085

    work page doi:10.1371/journal.pbio.1001085 2011

  53. [53]

    Reduced H+ channel activity disrupts pH homeostasis and calcification in coccolithophores at low ocean pH

    Kottmeier DM, Chrachri A, Langer G, Helliwell KE, Wheeler GL, Brownlee C. Reduced H+ channel activity disrupts pH homeostasis and calcification in coccolithophores at low ocean pH. Proc Natl Acad Sci U S A. 2022;119(19):e2118009119. doi:10.1073/pnas.2118009119

    work page doi:10.1073/pnas.2118009119 2022

  54. [54]

    Proton Channels are Present in Cell Membranes of the Breast Cancer Cell Line MDA MB 231 and Affect Recovery from an Acid Load

    Morgan D, Mc Intire P , Cherny V , Smith S, Musset B, DeCoursey T. Proton Channels are Present in Cell Membranes of the Breast Cancer Cell Line MDA MB 231 and Affect Recovery from an Acid Load. Biophys J. 2015;108(2):587a. doi:10.1016/j.bpj.2014.11.3200

    work page doi:10.1016/j.bpj.2014.11.3200 2015

  55. [55]

    Cancer statistics, 2024

    Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49

    work page 2024

  56. [56]

    Why do patients with cancer die? Nat Rev Cancer

    Boire A, Burke K, Cox TR, et al. Why do patients with cancer die? Nat Rev Cancer. 2024;24(8):578-589

    work page 2024

  57. [57]

    The present and future of the Cancer Dependency Map

    Arafeh R, Shibue T, Dempster JM, Hahn WC, Vazquez F . The present and future of the Cancer Dependency Map. Nat Rev Cancer. 2025;25(1):59-73

    work page 2025

  58. [58]

    Cancer an attack on cytologism

    Smithers DW. Cancer an attack on cytologism. The Lancet. 1962;279(7228):493-499. doi:10.1016/S0140-6736(62)91475-7 Figures Figure 1. Hallmarks of cancer. (a) This panel presents the traditional hallmarks of cancer, with a strong emphasis on a genetic-based explanatory mechanism. (b) This panel also considers the embryonic hallmarks of cancer. The embryo s...

    work page doi:10.1016/s0140-6736(62)91475-7 1962